Medical device injection systems manufacturer with digital health integration
Ypsomed manufactures injection systems and on-body devices for chronic disease self-administration, serving pharma and biotech partners globally. The tech stack is enterprise-operational (SAP, Anaplan, MES, NiceLabel, Siemens NX) rather than consumer-facing, reflecting a B2B manufacturing business. Hiring velocity is accelerating with engineering roles dominating the open slate—suggesting product platform expansion and digital health integration work, visible in active projects around MES interface integration and new technical solutions alongside traditional manufacturing improvement cycles.
Ypsomed designs and manufactures injection systems, autoinjectors, and on-body infusion devices for patient self-administration of liquid medications. The company sells to pharmaceutical and biotech firms globally, acting as their contract device partner. With 2,000+ employees and a network of manufacturing facilities worldwide, Ypsomed operates across product development, precision manufacturing, and supply chain. The business bridges traditional medical device manufacturing (springs, molding, assembly) with emerging digital health services, positioning devices to integrate with software platforms and connected health ecosystems.
Enterprise operations: SAP and S/4HANA for ERP, Anaplan for planning, MES (manufacturing execution system), Siemens NX for CAD, NiceLabel for labeling, Jira and Confluence for development collaboration.
Ypsomed operates a global network of manufacturing facilities and is headquartered in Burgdorf, Switzerland. Current hiring is concentrated in Switzerland.
Other companies in the same industry, closest in size